Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
about
Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasisThe endothelial border to health: Mechanistic evidence of the hyperglycemic culprit of inflammatory disease acceleration.The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report.
P2860
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@ast
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@en
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@nl
type
label
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@ast
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@en
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@nl
prefLabel
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@ast
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@en
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@nl
P2860
P356
P1476
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
@en
P2093
Marwa R Al-Badri
Sami T Azar
P2860
P356
10.1177/2042018814543483
P577
2014-04-01T00:00:00Z